Table 1.
Baseline characteristics according to the presence or absence of comorbid diabetes, hypertension, or dyslipidemia
| Diabetes | Hypertension | Dyslipidemia | ||||
|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | |
| N | 53 | 832 | 278 | 607 | 292 | 593 |
| Age (years) | 71.6 ± 6.6* | 68.5 ± 8.1 | 72.1 ± 7.8* | 67.1 ± 7.6 | 69.2 ± 8.0* | 68.4 ± 8.0 |
| Women (men) | 46 (7) | 807 (25) | 267 (11) | 586 (21) | 288 (4) | 565 (28) |
| BMI (kg/m2) | 23.1 ± 3.2 | 22.1 ± 3.1 | 23.1 ± 3.3 | 21.8 ± 2.8 | 22.4 ± 3.0 | 22.1 ± 3.1 |
| Lumbar spine BMD (g/cm2) | 0.668 ± 0.094 | 0.669 ± 0.086 | 0.672 ± 0.090 | 0.668 ± 0.084 | 0.668 ± 0.079 | 0.670 ± 0.090 |
| NTX (nmol BCE/mmol·Cr) | 42.7 ± 20.3* | 49.7 ± 22.8 | 48.9 ± 22.6 | 49.4 ± 22.7 | 48.6 ± 22.0 | 49.6 ± 23.0 |
| CTX (μg/mmol·Cr) | 197.1 ± 86.7* | 262.5 ± 130.1 | 256.7 ± 115.5 | 259.4 ± 134.6 | 252.5 ± 131.2 | 262.2 ± 127.3 |
| BAP (U/L) | 28.2 ± 8.9 | 30.8 ± 10.3 | 31.3 ± 10.5 | 30.3 ± 10.0 | 29.5 ± 9.8* | 31.4 ± 10.4 |
BMI Body mass index, BMD bone mineral density, NTX N-terminal telopeptide of type 1 collagen, CTX C-terminal telopeptide of type 1 collagen, BAP bone-specific alkaline phosphatase
* Significantly different from the group without each comorbidity (p < 0.05)